An open-label study suggests that patients with type 2 diabetes receiving poor control while taking sulfonylurea improve more by adding premeal inhaled insulin vs metformin. (CME)
Medscape Medical NewsLaurie Barclay,Gary Vogin,Desiree Lie
Click Here to read the entire article...